While studies of the prevalence of major depressive disorders in elderly people have produced rates of 1% to 2%, depression that is clinically significant has been shown to have a prevalence of at least 10% among older people and represents the most common mental disorder in later life. Most of these depressed older people, however, do not receive any treatment for their depression. 1 Prominent symptoms and syndromes of anxiety commonly accompany late life depression in the community 2 and may contribute to the low level of detection of the primary depressive disorder and to inappropriate treatment with benzodiazepines. As part of a naturalistic study of mental disorders among elderly people living in the community in Dublin 3 we studied the influence of concurrent anxiety symptoms on the likelihood of them receiving pharmacological treatment for depression.
Subjects, methods, and results
People aged 65 years and over on the practice lists of five urban general practices and not living in residential care were identified. We interviewed 1737 participants (82%) with the geriatric mental state and automated geriatric examination for computer assisted taxonomy instrument, which generates "cases" and "subcases" of mental disorder (subcase level representing symptoms not reaching the criteria for case level disorder).The level of depression among cases has been shown to correspond with what psychiatrists usually recognise as a depressive disorder and has been validated against the combined categories of major depression and dysthymia from the Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III), with good agreement. 4 In addition to the primary diagnosis each subject is allocated a level of confidence on all (eight) diagnostic clusters and, therefore, the presence of symptoms or disorders comorbid with the principal diagnosis is recorded. Current use of psychotropic drugs was recorded by direct inspection of medications.
There were 184 (11%) cases of depression among the elderly people. Of these, 84 (46%) were receiving a psychotropic drug, with a similar proportion of depressed men (22/53, 42%) and women (62/131, 47%). Sixty four (35%) depressed participants were taking a benzodiazepine and 34 (19%) were taking antidepressant medication. Of the 184 depressed people, 36 (20%) had a comorbid anxiety disorder (case level anxiety or phobia), 115 (63%) had concurrent anxiety symptoms (anxiety, phobic, or obsessional symptoms at subcase level), and 33 (18%) were free of anxiety. The table compares the use of psychotropic drugs in these three subgroups. The presence of concurrent anxiety in depression was significantly associated with the use of any psychotropic drug ( 2 8.0; df = 2; P = 0.02), a benzodiazepine ( 2 9.3; df = 2; P = 0.01), or an antidepressant ( 2 6.6; df = 2; P = 0.04).
Comment
Unless elderly people with depression have concomitant symptoms of anxiety they are less likely to receive BMJ 1999; 318:579-80 pharmacological treatment in primary care. To our knowledge no previous study has examined this issue. Sartorius et al showed that the presence of comorbid anxiety disorders with depression increased the chance that depression would be recognised and some treatment offered but excluded elderly patients and did not consider depression with concomitant anxiety symptoms of less severity than anxiety disorder.
5
Whereas depression in later life was undertreated, depression with prominent anxiety did tend to receive some pharmacological intervention, whether appropriate treatment or otherwise. It would seem that the concurrent symptoms of anxiety rendered the depression "loud" and attracted the attention of the doctor. Having recognised this important aspect of the presentation of depression in later life we may be able to direct attempts to improve diagnosis and to alter the practice of symptomatic treatment with benzodiazepines in a more focused way. The corollary to anxious depression being loud is, of course, that depression which is not flagged by symptoms of anxiety remains "silent" and is at particular risk of being missed.
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Competing interests: None declared. A fairy story that I now understand There's nothing really new
Once upon a time a King had a little daughter for whom he would do anything. She wanted an apple made of pure gold, and because he was rich he had one made for her. The princess wanted a pony with a coat of the purest white and because he was powerful, he had the land searched and the best one sent to the palace for her. One night she looked into the dark sky from her bed chamber and asked for the moon. The King sent for the court astronomer and said, "Tell me about the moon." "The moon, sire," he said, "is three miles above the earth and made of green cheese." The King sent for his engineer, and said, "My daughter wants the moon. Please get it down for her." "Sire," he said, "what the astronomer did not tell you is that the moon is in fact very large and heavy and suspended on thick chains. Even with my longest cranes I could not reach it, and even with my best tower of pine tree scaffolding, it would be impossible to free it and bring it to earth." The King, exasperated, shared the dilemma with the court jester. "Let me talk with her, Sire," he said.
He told the Princess her bedtime story and looking out of the window together he asked, "What is the moon like?" "The moon is the size of my thumb nail." "How do you know?" asked the jester. "Look," she replied, "I can just cover it with the end of my thumb, and it is made of beautiful silver." The court jeweller made a moon to the Princess's specifications and she was content.
To complete the story I would have to explain how they coped with the reappearance of the silver moon in the sky at the same time as the Princess had the moon hanging around her neck on a little chain, but that is enough of the fairy story for now.
I was reminded of the tale by the recent reports of the successful use of a tiny impeller pump as a replacement heart. Since the 1960s surgeons have told engineers that the heart is a pumping chamber, of such and such a capacity and pressure characteristics, with inflow and outflow valves. Like the court engineer, they have tried to please the King. They have been largely defeated by the combined difficulties of the mechanics of the pumping chamber, pistons and pusher plates, the procoagulant nature of the materials, and the need for two valves which will neither fail nor clot. The brilliance of the little pump implanted with such success by Steve Westaby in Oxford is that it does what the heart does, but in a way achievable by engineers. Someone, somewhere managed to get beyond a description of the heart as we know it and asked the question, in bare essentials, what do you want the heart to do? The engineered device does not work on intermittent volume displacement, which is the solution reached by evolutionary biology, but by a continuous stream of blood driven by an electromagnetically coupled impeller spinning in the blood stream, creating continuous unidirectional flow.
The point that the story brings to mind is that when surgeons talk to scientists, bioengineers, or computer programmers, they are very ready to tell them what they want but it may be not what they really need.
Tom Treasure, professor and cardiac surgeon, St George's Hospital, London
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